Tech Company Financing Transactions
NFlection Therapeutics Funding Round
F-Prime Capital, venBio and private investors participated in a $20 million Series A funding round for NFlection Therapeutics. The round was announced on 6/10/2020.
Transaction Overview
Company Name
Announced On
6/10/2020
Transaction Type
Venture Equity
Amount
$20,000,000
Round
Series A
Investors
F-Prime Capital (Lead Investor)
venBio (Lead Investor)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
714 Woodcrest Rd.
Wayne, PA 19087
USA
Wayne, PA 19087
USA
Phone
Undisclosed
Website
Email Address
Overview
We are a biotechnology company focused on the discovery and development of effective, targeted therapies for rare disorders driven by aberrant activation of the RAS pathway (RASopathies).
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Christopher Powala
Chief Financial Officer
Diane Marcou
Chief Medical Officer
Guy Webster
VP - Operations
Brian Beger
Browse more venture capital transactions:
Prev: 6/10/2020: MPOWER Financing venture capital transaction
Next: 6/10/2020: YugaByte venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs